CARDIATEC BIOSCIENCES
CardiaTec is a digital biotechnology venture combining the power of AI and expert talent to redesign cardiovascular drug discovery.
CARDIATEC BIOSCIENCES
Social Links:
Industry:
Artificial Intelligence Biotechnology Life Science
Founded:
2021-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.cardiatec.ai
Total Employee:
1+
Status:
Active
Total Funding:
1.4 M GBP
Investors List
Crista Galli Ventures
Crista Galli Ventures investment in Pre Seed Round - CardiaTec Biosciences
APX Ventures
APX Ventures investment in Pre Seed Round - CardiaTec Biosciences
University of Cambridge Enterprise
University of Cambridge Enterprise investment in Pre Seed Round - CardiaTec Biosciences
Laidlaw Scholars Ventures
Laidlaw Scholars Ventures investment in Pre Seed Round - CardiaTec Biosciences
O2h Ventures
O2h Ventures investment in Pre Seed Round - CardiaTec Biosciences
Official Site Inspections
http://www.cardiatec.ai Semrush global rank: 8.72 M Semrush visits lastest month: 261
- Host name: kuat-lon2.krystal.uk
- IP address: 77.72.1.52
- Location: United Kingdom
- Latitude: 51.4964
- Longitude: -0.1224
- Timezone: Europe/London
More informations about "CardiaTec Biosciences"
CardiaTec Biosciences
Apr 9, 2022 CardiaTec is a TechBio company leveraging large scale multiomics data to discover novel cardiovascular therapeutics. ... CardiaTec honoured as the AI Startup of the Year at the …See details»
CardiaTec joins the BioEscalator - AI in cardiovascular drug discovery
Apr 17, 2024 COO & Co-Founder of CardiaTec Biosciences. Alumni of the MPhil in Bioscience Enterprise, University of Cambridge. Prof Namshik Han. Group Leader at Milner Institute, …See details»
CardiaTec Biosciences - Crunchbase Company Profile …
CardiaTec is a TechBio business that uses computational tools to unravel the biology underlying cardiovascular illness. CardiaTec uses massive and high-dimensional human omics data to better understand complicated disease …See details»
Heart disease is the world’s biggest killer - TechCrunch
Sep 9, 2024 CardiaTec had previously raised $1.8 million in pre-seed funding, and with this fresh $6.5 million in cash, the company is well-financed to extend its proprietary data-gathering efforts, wet lab ...See details»
CardiaTec Company Profile 2024: Valuation, Funding & Investors
Operator of an artificial intelligence (AI) drug target discovery company intended to transform the biology behind cardiovascular disease. The company develops a target identification and …See details»
Member profile: CardiaTec Biosciences Ltd | BIA
CardiaTec is a University of Cambridge spin-out, applying artificial intelligence on large-scale multi-omic data to develop the next generation of cardiovascular disease drug targets. About …See details»
CardiaTec Biosciences - Forbes
CardiaTec Biosciences on the 2024 30 Under 30 - Europe - Science & Healthcare - Thelma Zablocki and Raphael Peralta are cofounders of CardiaTec, an AI-enabledSee details»
CardiaTec: Revolutionising Heart Health
Nov 7, 2024 Company: CardiaTec Location: Cambridge. Founded: 2021. Founders: Raphael Peralta (CEO), Thelma Zablocki (COO), Dr. Namshik Han (CTO) Written by: Lucy Ahern …See details»
CardiaTec raises $6.5M Seed for cardiovascular drug discovery
Sep 10, 2024 CardiaTec, a techbio company decoding the biology behind cardiovascular disease, today announces securing $6.5m in seed funding.The new funds will allow CardiaTec …See details»
AI drug target discovery company co-founded by …
Jul 15, 2022 CardiaTec, a company co-founded by Milner Head of Computational Biology Dr Namshik Han, has secured £1.4 million pre-seed investment to combat cardiovascular diseases using artificial intelligence (AI).. …See details»
Cambridge Enterprise joins £1.4m pre-seed round for …
Jul 6, 2022 Cambridge Enterprise has joined a £1.4 million pre-seed investment in CardiaTec, an AI drug target discovery company specialising in cardiovascular disease.The round was led by Laidlaw Scholars Ventures and APEX Ventures …See details»
AI Cardiovascular Precision Tool wins SCI Contest - soci
Mar 18, 2022 CardiaTec – University of Cambridge alumni – an AI drug discovery company specialising in cardiovascular disease Happy BioPatch – Oxford University and Manchester …See details»
CardiaTec snaps $6.5M seed funding to revolutionise …
Sep 10, 2024 CardiaTec’s focus on cardiovascular disease—a long-neglected therapeutic area—comes at a time when computational drug discovery is increasingly recognised as the …See details»
CardiaTec Secures $6.5M Seed Funding to Advance Its Multi-omics …
Sep 10, 2024 CardiaTec, a TechBio company employing computational methods to decode the biology behind cardiovascular disease, has raised $6.5M in seed funding led by San Francisco …See details»
CardiaTec raises seed round for cardiovascular disease innovation
Sep 10, 2024 CardiaTec is a spin-out from the Han Lab at the University of Cambridge and works with over 65 hospitals across the US and the UK. What they're saying : "With strong …See details»
Why We Invested: CardiaTec - Pioneering AI-Driven ... - LinkedIn
Sep 10, 2024 By leveraging AI and multi-omics data to uncover new disease pathways and drug targets, CardiaTec has the potential to dramatically accelerate the development of more …See details»
Cambridge startup analyses ‘multi-omics’ data to discover new
Sep 10, 2024 CardiaTec has raised $6.5mn in seed funding September 10, 2024 - 4:00 am Cambridge-based CardiaTec has raised $6.5mn to accelerate drug discovery for …See details»
Cambridge's CardiaTec gets €1.6M to tackle cardiovascular …
CardiaTec, a Cambridge-based firm developing an AI platform to discover drugs for cardiovascular diseases, announced on Wednesday that it has raised £1.4M (approximately …See details»
CardiaTec raises £1.4m to tackle heart disease with AI - UKTN
Jul 6, 2022 Cambridge-based health tech startup CardiaTec has secured a £1.4m pre-seed investment to further develop its AI-driven cardiovascular disease treatment. Founded at the …See details»
AI Meets Heart Disease: Revolutionizing Treatment with ... - Medium
CardiaTec, a spinout from Cambridge University, stands at the forefront of harnessing AI to combat cardiovascular diseases (CVDs) — the leading cause of death globally, according to …See details»